MammaPrint

Growth in Personalized Medicine to Drive Alliances Between Diagnostics and Pharmaceutical Industries, According to PricewaterhouseCoopers

... adoption of new diagnostic technologies in the guidelines of important clinical communities, which should accelerate their market adoption. Agendia's mammaprint (a DNA-based test for evaluating an individual's risk of breast cancer spreading to other sites) is an example of a new diagnostic tool to help person...

Agendia Appoints Oncologist Richard A. Bender as Vice President and Chief Medical Officer

...e joining Agendia at such a pivotal and exciting time in the company's development," said Dr. Bender. "Their FDA cleared breast cancer prognostic test mammaprint clearly shows that Agendia is becoming an important diagnostic provider for the management of breast cancer. The company's promising oncology pipeline...

MammaPrint(R) Breast Cancer Test Shown To Be Powerful Tool for Prognosis Prediction in Postmenopausal Breast Cancer Patients

...der age breast cancer patients as well. To date, mammaprint has received two clearances from the Food and Drug...e first clearance in February of this year cleared mammaprint for safety and effectiveness under the In Vitro Di...oston, USA between 1985 and 1997 were subjected to mammaprint gene expression analysis. MammaPrint, having a dig...

Agendia's MammaPrint(R), the Only FDA-Cleared Breast Cancer Prognosis Test, is Now Widely Available to U.S. Patients

...wing shipping of tumor biopsies at ambient temperature, greatly facilitating the logistical process of sample handling. "We are very pleased to make mammaprint widely available to U.S. patients and their physicians," said Bernhard Sixt, chief executive officer and co-founder of Agendia. "We believe it will pl...

FDA Clears Breast Cancer Specific Molecular Prognostic Test

...cular test that profiles genetic activity. The mammaprint test uses the latest in molecular technology to pr...es located in the tumor. Prognostic tests like the mammaprint can measure the activity of these genes, and thus ...en on the market since 2005. "Clearance of the mammaprint test marks a step forward in the initiative to bri...

MammaPrint in Medical Technology

Agendia's Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations

HUNTINGTON BEACH, California and AMSTERDAM, June 23 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the inclusion of its breast cancer recurrence test MammaPrint in St. Gallen's 2009 International Expert Consensus on the primary therapy of early breast ...

/C O R R E C T I O N -- Agendia B.V./

... -- Agendia's Breast Cancer Recurrence Test mammaprint Included in International St. Gallen Expert Consen...the inclusion of its breast cancer recurrence test mammaprint in St. Gallen's 2009 International Expert Consensu...not useful in clinical decision making. Currently, mammaprint is the only breast cancer recurrence assay availab...

Agendia's Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients

...t(R), was used to differentiate between patients at high and low risk for recurrence. HER2+ patients are commonly identified as high risk, yet mammaprint was able to identify a low risk subgroup of HER2+ patients, who subsequently experienced a 10 year disease-free survival of close to 90 percent even i...

Agendia's MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

...omplete response (pCR) rate and the results of the mammaprint test. "Physicians are increasingly supportive of mammaprint in clinical practice because they believe it provi...hese findings suggest tumors with a poor prognosis mammaprint signature are sensitive to chemotherapy. A...

Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium

...he Netherlands About MammaPrint(R) mammaprint is the first 'in vitro diagnostic multivariate ind... early metastasis risk. In planning treatment, the mammaprint test result provides a doctor with a clear rationa...nical information and pathology tests. All mammaprint tests are conducted in Agendia's CLIA-certified se...

Agendia's MammaPrint(R) Included in 2008 Dutch Institute for Healthcare Improvement CBO Guidelines

...cer Consultation Group (NABON). The inclusion of mammaprint in CBO's updated clinical practice guidelines repr...new guidelines acknowledge the prognostic power of mammaprint in general and highlight its ability to identify s...ing additional knowledge. "We are delighted that mammaprint has been included in the CBO guidelines," said Ber...

MammaPrint in Biological Technology

Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer

HUNTINGTON BEACH, California, and AMSTERDAM, February 18 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that a study demonstrating the direct predictive ability of its breast cancer recurrence test, MammaPrint(R), has been published in Breast Cancer Re...

Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards

...ading product, MammaPrint(R), is commercialized globally to aid physicians in making informed treatment decisions for breast cancer patients. In 2007, mammaprint became the first in vitro diagnostic multivariate index assay (IVDMIA) cleared by the FDA. FDA clearance requires clinical and analytical validation a...

Agendia Opens CLIA-Registered U.S. Genomics Laboratory

...ment, and pathologist Dr. Chynel Henning, Laboratory Director. "Our new genomics lab's capacity will allow us to meet the increasing demand for mammaprint across the United States and give physicians and patients optimal test result turnaround and unmatched service and support," noted Jan Groen, Ph.D., C...

Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting

... A. M. Glas About MammaPrint(R) mammaprint is the first 'in vitro diagnostic multivariate ind... early metastasis risk. In planning treatment, the mammaprint test results provide doctors with a clear rational...inical information and pathology tests. All mammaprint tests are conducted in Agendia's CLIA-accredited s...

Agendia Presents Data Supporting MammaPrint's Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference

...March 2009 Poster 0063 Comparison of mammaprint and TargetPrint Results with Clinical Parameters i...2 March 2009 Poster 0072 The 70-gene mammaprint Prognosis Signature for Optimal Risk Stratificatio...2 March 2009 Poster 0073 The 70-gene mammaprint Signature Is Predictive for Chemotherapy Benefit i...

Agendia's Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL

...euwenhoek Hospital (NKI-AVL). The NKI-AVL believes mammaprint provides better guidance for decisions regarding a...s in the MINDACT trial NKI-AVL is already offering mammaprint to patients and will continue to do so. In future, however, NKI-AVL will also make mammaprint available to patients who fall outside MINDACT's i...

Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets

... the right partner for the successful expansion of mammaprint and CupPrint into these additional European market...e valuable information provided by these tests." mammaprint is a clinically proven, highly accurate gene expre...y worldwide. "Having followed the development of mammaprint and CupPrint, we are excited about the opportunity...

Agendia's MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform

...ch government. "We are honored that the value of mammaprint has been recognized at a governmental level for it...ients will benefit from personalized treatment." mammaprint was among four healthcare innovations awarded by D...e suffering from cancer, and new technologies like mammaprint are changing the way oncologists are treating this...

MammaPrint(R) Breast Cancer Test Provides Valuable Insight for Personalized Treatment Decisions

..."These studies demonstrate the clinical utility of mammaprint in helping physicians make more informed decisions...cipated in both studies. "Prognostic tests such as mammaprint have ushered in a new era in personalized medicine...ive trial to assess the clinical implementation of mammaprint in 15 community hospitals in The Netherlands. Of 4...